Robin Patel, M.D., Chair of the Division of Clinical Microbiology in the Department of Laboratory Medicine and Pathology, has been appointed to the council of the National Institute of Allergy and Infectious Diseases (NIAID). She will serve a four-year term.
The council will advise, assist, consult with, and make recommendations to the Secretary of Health and Human Services and the Director of the National Institutes of Health on matters related to immunology, immunologic and allergic diseases, microbiology and infectious diseases, virology, epidemiology, tropical diseases, sexually transmitted diseases, AIDS, and biodefense research. The advisory council will also review and make recommendations regarding grant applications to support biomedical research and research training activities.
About the National Institute of Allergy and Infectious Diseases
In mid-1948, the National Institute of Health became the National Institutes of Health (NIH) with the creation of several individual institutes. Later that year, the Rocky Mountain Laboratory and the Biologics Control Laboratory joined the NIH Division of Infectious Diseases and Division of Tropical Diseases to form the National Microbiological Institute. In 1955, Congress changed the name of the National Microbiological Institute to the National Institute of Allergy and Infectious Diseases to reflect the inclusion of allergy and immunologic research.
As NIAID continues to pursue progress in understanding, treating, and preventing infectious and immunologic diseases, it recognizes that new challenges to public health continue to emerge. NIAID will continue its tradition of supporting innovative scientific approaches to address the causes of these diseases and find better ways to prevent, diagnose, and treat them.
In addition to serving as chair of Mayo Clinic's Division of Clinical Microbiology, Dr. Patel also holds a number of leadership roles including serving as director of the Infectious Diseases Research Laboratory.